Dr. MiltieAtlas by Dr. Miltie™Healthcare Grant Intelligence
Active — Willing & Qualified ContractingAtlas Opportunity Score 82/100
ME-DACF-PFAS-BLOOD-SERUM-WQ-0920250871MaineInfectious Disease & Tuberculosis

Maine DACF PFAS Blood Serum Testing — Willing & Qualified Laboratory Contracting Pathway

Funding$425,000 current Quest Diagnostics contract for August 1, 2025 through July 31, 2027. DACF reimburses eligible uncovered costs up to $250 per test for analysis plus up to $50 per test for collection, delivery, and other costs, for a maximum of $300 per test.
DeadlineActive Willing & Qualified contracting pathway through July 31, 2027. Maine does not publish a separate new-provider application deadline, closing time, or time zone for prospective willing-and-qualified laboratories.
Last verifiedSeptember 19, 2026
Required next actionTreat Quest Diagnostics as the current incumbent. For any prospective additional laboratory, verify CLIA certification, required PFAS LC-MS/MS capability, proficiency testing, Maine diagnostic-ordering relationships, insurance-billing workflow, current DACF W&Q availability, and funding before applying CRM, Atlas_Email_Queue, Email Opt-Out, sent-history, reply, bounce, approval, deadline, and exact-opportunity deduplication controls.

Broad Eligibility

Laboratories must be able to collect human blood serum and analyze specified PFAS analytes using liquid chromatography-tandem mass spectrometry; hold CLIA certification for human-specimen testing; use methods comparable to CDC Method 6304.09; quantify concentrations above 2,000 ng/mL; participate in approved proficiency testing; report analytes in ng/mL; and maintain business relationships with Maine health-care providers so tests can be ordered and insurance billed before DACF.

Atlas Analysis

Atlas Opportunity Score: 82/100 because this is an active Maine public-health diagnostic-testing pathway with defined technical requirements and a statewide clinical ordering network. N9+ Fit Score: 0/100 because the procurement is for specialized laboratory analysis and specimen collection rather than telehealth, remote-exam technology, or clinical-device deployment. Dr. Miltie direct-prime fit: 0/100 on current evidence because the required CLIA laboratory certification, PFAS LC-MS/MS capability, proficiency testing, and laboratory insurance-billing infrastructure are not established.

Opportunity Overview

The Maine Department of Agriculture, Conservation and Forestry PFAS Fund maintains an active Willing & Qualified contracting pathway for laboratories capable of collecting and analyzing human blood serum for specified PFAS compounds. The current State procurement record, CT NOI 0920250871, runs through July 31, 2027. The current named provider is Quest Diagnostics LLC, but the Procurement Justification Form expressly states that DACF will work with all vendors that satisfy the Willing & Qualified requirements.

Current Funding and Reimbursement

The current Quest Diagnostics contract is listed at $425,000 for August 1, 2025 through July 31, 2027. The PJF states that the PFAS Fund will reimburse the portion not covered by insurance for eligible individuals up to $250 per test for laboratory analysis and up to $50 per test for collection, delivery, and all other costs, for a maximum State payment of $300 per test. The PJF notes that list pricing for PFAS blood serum testing exceeds $600.

Required Services

The provider must develop a workflow with DACF, collect and analyze human blood serum for specified PFAS compounds, report results to ordering medical providers, bill insurance to the maximum extent possible, and invoice DACF only for the eligible portion not compensated by insurance.

Minimum Qualifications

A willing and qualified vendor must be able to collect human blood serum samples and analyze them using liquid chromatography-tandem mass spectrometry for at least PFOS, PFOA, PFNA, PFDA, PFHxS, and PFHpA. The laboratory must be CLIA-certified for human-specimen testing, use methods comparable to CDC Method 6304.09 for accuracy, precision, and detection limits, quantify concentrations above 2,000 ng/mL, participate in an approved proficiency-testing program, and report each analyte in ng/mL. The vendor must also have business relationships with Maine health-care institutions, practices, and clinicians so that PFAS serum tests can be ordered through ordinary diagnostic workflows and insurance can be billed before DACF.

Program Context

The PFAS Fund pays eligible testing costs not otherwise covered by health insurance for people exposed to PFAS associated with land application of residuals in Maine. Current DACF program materials state that eligible individuals include qualifying farmers, farm workers, household members, and certain other residents exposed through PFAS-contaminated property, subject to the Fund’s rules and case-specific eligibility review.

Atlas Relevance

This is a legitimate Maine diagnostic-testing and public-health contracting pathway. It does not fund remote examination technology, telehealth platforms, or N9+ equipment. Dr. Miltie, LLC is not a viable direct prime on current evidence because the pathway requires specialized CLIA-certified laboratory capabilities, PFAS mass-spectrometry methods, proficiency testing, and established diagnostic-ordering and insurance-billing relationships.

Next Action

Treat Quest Diagnostics as the current incumbent, not an unsent applicant. For any prospective additional laboratory, verify the complete technical and CLIA qualification set, current DACF willingness to add providers, reimbursement terms, Maine ordering-network capability, and funding availability before creating CRM or outreach records. Apply all Atlas_Email_Queue, Email Opt-Out, sent-history, reply, bounce, approval, deadline, and exact-opportunity deduplication controls before any customer-facing action.

Official source: Maine Office of State Procurement Services, CT NOI 0920250871, PFAS blood serum testing.

Source verificationOfficial government source · www.maine.govAtlas last verified this record September 19, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗